Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abhiraami Kavirajan has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bactericidal and Antineoplastic Properties of Phyto-Formulated Nano Gold Composite Using Dwarf Copperleaf Plant

    by Gayathri Vijayakumar, Abhiraami Kavirajan, Keerthi Neminla, Senthil Kumaran Rangarajulu

    Biogenic synthesis of gold nanoparticles using plant extracts has been widely explored for biomedical applications due to its eco-friendly and cost-effective nature. In this study, gold nanoparticles were phytoformulated using an ethanolic extract of dwarf copper leaf. Their physicochemical properties, antineoplastic activity against MCF-7 breast cancer cells, and bactericidal efficacy against selected pathogenic microorganisms were systematically evaluated. The phyto-synthesized AuNPs show potential as an antineoplastic agent, significantly dropping the viability of MCF-7 breast cancer cells when administered at higher concentrations. Comprehensive characterization revealed that the phyto-formulated AuNPs were predominantly spherical with sizes ranging from 15–38 nm as observed by TEM, while XRD analysis confirmed their crystalline nature. Furthermore, FT-IR analysis determined the plant extract’s functional groups, which served as both reducing and stabilizing agents during synthesis. Additionally, the phyto-formulated AuNPs showed bactericidal efficacy against several microorganisms, including Bacillus cereus, Salmonella typhimurium, Staphylococcus epidermidis, and Serratia species. Particularly, the phyto-formulated AuNPs were effective against B. cereus and Serratia species. The present results showed that the phyto-formulated AuNPs could be used in biomedical contexts for bactericidal action and medication delivery. By using this cost-effective and eco-friendly nanobiotechnology method, AuNPs can enhance drug delivery and efficacy with lower toxicity effects associated with conventional chemotherapies.